Magnar Kvilhaug

[Magnar Kvilhaug @MagnarKvilhaug]

#ticklemetuesday @KennedyNation the elfabet

[Magnar Kvilhaug @MagnarKvilhaug]

The fight for #340B status quo has started. @DrugChannels predicted the response. With #COVID19 & election season, how much attention will this fight attract. https://t.co/M9n0SxA40S

[Magnar Kvilhaug @MagnarKvilhaug]

@DrugChannels has been on this story for years. Diverse voices like @ScottAdamsSays @MariaBartiromo & @BretBaier can find so many market distortions in this story about a broke 340B system. Pharma isn’t the angel here, they Are net positive by cutting out smoke & mirrors.

[Drug Channels @DrugChannels]

Per @LillyPad, the #340B discounted price for #insulin is 10 cents per 10-mL vial. That's 0.04% of the product’s list price and far below cost. https://t.co/OhECtNmX24

Under #340B, patients shoulder the burden of financing safety-net support for large health systems.

[Magnar Kvilhaug @MagnarKvilhaug]

@DrugChannels has been consistent in the analysis & persistent in reporting the effects on patient out of pocket payments that can exceed the 340B cost. A benign program that got on that crowded road paved with good intentions.

[Drug Channels @DrugChannels]

My latest @WSJ opinion piece: The Federal Program That Keeps #Insulin Prices High https://t.co/uWOPYJYfOQ

a.k.a. How the #340B #Drug Pricing Program lost its way with contract #pharmacies

[Drug Channels @DrugChannels]

Huh? A group opposed to #rebate reform funds a survey that finds opposition to rebate reform–yet survey questions & methodology are top secret? And this is presented as totally credible research? https://t.co/HYSr9AaQkm

C’mon, @NicholasFlorko @statnews. You can do better.

[Drug Channels @DrugChannels]

Irony alert via @JAMA_current 🙄
1) Authors discover net #insulin #drug prices declining https://t.co/cnhkQ4hOzy #GrossToNetBubble
2) Same authors had previously attributed "rising drug costs" to list price growth of existing drugs, "particularly insulin" https://t.co/4Fq8yaQvt9

[Drug Channels @DrugChannels]

Fresh evidence of #hospitals' struggles to penetrate #PBM and payer networks: @PremierHA $PINC #GPO is selling its #specialty #pharmacy to @CVSHealth $CVS. Revenues are ~$470M (bit higher than our estimates). Another #specialty deal for $CVS! https://t.co/beI6IEvNAD

[Magnar Kvilhaug @MagnarKvilhaug]

@MorningsMaria great interview with Alex Azar. Transparency critical to pricing. Rebates are now front and center. Adam Fein’s @DrugChannels consistent focus on #PBM process is paying off. https://t.co/oTlyEeril8 Go SpongeBob.

[Magnar Kvilhaug @MagnarKvilhaug]

Peeling back the layers.

[Alex Azar @SecAzar]

This proposal has the potential to usher in the most significant change in how Americans’ drugs are priced at the pharmacy counter, ever, and ease the burden of the sticker shock that millions of Americans experience every month for the drugs they need. https://t.co/gOlQVWsGpt

[Bret Baier @BretBaier]

oh dear...

[Magnar Kvilhaug @MagnarKvilhaug]

The #asembia18 Summit begins.

[Magnar Kvilhaug @MagnarKvilhaug]

@PharmacyPodcast 👍

[Magnar Kvilhaug @MagnarKvilhaug]

@PharmacyPodcast @PharmacyPodcast Where will you be stationed? Looking to stop by and say hi.

[Magnar Kvilhaug @MagnarKvilhaug]

Osprey back in MA! They are monitoring training runs for #Asembia18 5K. Looking forward to reconnecting and meeting those new to @asembiarx summit. Always a great learning event! See you there from https://t.co/mrk4sbfojc

[Drug Channels @DrugChannels]

Spin zone! @ExpressScripts $ESRX #PBM defends #copay #accumulator by suggesting manufacturers should be "lowering the cost of drugs." What happens when manufacturer lowers #drug cost with a bigger rebate, but patient doesn't share in the savings?? https://t.co/UlpUNrmOC5

[Magnar Kvilhaug @MagnarKvilhaug]

Halloween news. Amazon acquires wholesale #pharmacy lic. Insurance will be a learn. Is ca$h play 1st entry? Boo BlinkHealth,GoodRX & others?

[Magnar Kvilhaug @MagnarKvilhaug]

@DrugChannels @CVSHealth @Aetna Hmmm

[Drug Channels @DrugChannels]

Crazy times for #drug #channel! @CVSHealth $CVS in talks to buy @Aetna $AET https://t.co/RGQ123qbsV

[AppaGrapha @AppaGrapha]

Why Do People Stop Taking Their Meds? Cost Is Just One Reason https://t.co/8JjDJaZd53 #pharmacist #pharmacy #Health #appagrapha